Sex and Chemotherapy

Sex is an important part of life. But can a cancer patient undergoing chemotherapy or radiation continue to have sex during these difficult treatments?

The short answer is that it's up to the patient (and their partner). The long answer is slightly more complicated.

There's no question that chemotherapy can affect one's interest in sex, on both the physical and psychological levels. The patient may be exhausted and entirely uninterested in sex, or he or she may be too stressed, too full of anxiety, to have any interest.

As the Cancer Research UK's page on Sex and Chemotherapy points out, "There's no medical reason to stop having sex during chemotherapy. The drugs won't have any long term physical effects on your performance or enjoyment of sex."

The only issue Cancer Research UK has with regards to sex and chemo concerns conception. They strongly advise against trying to become pregnant during chemotherapy, since the drugs may affect the child. They even recommend protection if the woman is on the pill, saying " We don't think that any of the drugs would get through, but there is a small chance that they could get into your bodily fluids so you need to protect your partner."

Cancer Research UK has additional information on:

How cancer can affect your sexuality and sex life
Sex and cancer for women
Sex and cancer for men
Sex and cancer for singles

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap